Etanercept (Enbrel)
Also known as Enbrel
Etanercept (trade name Enbrel) is a biopharmaceutical that treats autoimmune diseases by interfering with tumor necrosis factor (TNF; a soluble inflammatory cytokine) by acting as a TNF inhibitor. It has U.S. F.D.A. approval to treat rheumatoid, juvenile rheumatoid and psoriatic arthritis, plaque psoriasis and ankylosing spondylitis. TNF-alpha is the "master regulator" of the inflammatory (immune) response in many organ systems. Autoimmune diseases are caused by an overactive immune response. Etanercept has the potential to treat these diseases by inhibiting TNF-alpha.
Source: WikipediaEstimated Total Cost: $1759.86 for an average of 28 days supply
What is it prescribed for?
Patients are most commonly prescribed etanercept to treat rheumatoid arthritis, psoriasis, juvenile rheumatoid arthritis, and joint pain.
What drug interactions are known?
Critical Interactions
Significant Interactions
Loading...